Stock Market Today, June: Bio-Techne Surges on Merck Bid
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Identify the ideal low-cost index funds for retirement using transparent criteria and performance benchmarks to guide your choices.
27,037 articlesA high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Jamie Dimon argues that AI will reshape work but cautions against panic, highlighting retraining and internal job red...
This year, a familiar name in disruptive investing is turning heads as one of its picks climbs about 30%. Learn what ...
January delivered a painful wake-up call for Duolingo investors as the stock dropped sharply. This guide unpacks the ...
A midweek surge in Shiba Inu coincided with a broader crypto rebound. This guide breaks down why shiba bumped higher ...
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
As 2026 accelerates, a wave of deals reshapes the cybersecurity landscape. Analysts spotlight targets likely to be ac...
Uncover five key quotes from AMD's earnings call and what they could mean for the stock in 2026. Learn how to transla...
Dan Ives of Wedbush argues the AI revolution is still in its early innings, signaling multi-year upside for Nvidia an...
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...